| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |